BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23787783)

  • 41. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement.
    Rodrigues C; Batista AA; Ellena J; Castellano EE; Benítez D; Cerecetto H; González M; Teixeira LR; Beraldo H
    Eur J Med Chem; 2010 Jul; 45(7):2847-53. PubMed ID: 20363536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
    Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S
    Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
    Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
    Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines.
    Reis DC; Pinto MC; Souza-Fagundes EM; Rocha LF; Pereira VR; Melo CM; Beraldo H
    Biometals; 2011 Aug; 24(4):595-601. PubMed ID: 21221718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
    Caputto ME; Ciccarelli A; Frank F; Moglioni AG; Moltrasio GY; Vega D; Lombardo E; Finkielsztein LM
    Eur J Med Chem; 2012 Sep; 55():155-63. PubMed ID: 22840495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
    Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
    J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, spectroscopy, and biological properties of vanadium(IV)-hydrazide complexes.
    Ashiq U; Ara R; Mahroof-Tahir M; Maqsood ZT; Khan KM; Khan SN; Siddiqui H; Choudhary MI
    Chem Biodivers; 2008 Jan; 5(1):82-92. PubMed ID: 18205128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
    Vieites M; Otero L; Santos D; Toloza J; Figueroa R; Norambuena E; Olea-Azar C; Aguirre G; Cerecetto H; González M; Morello A; Maya JD; Garat B; Gambino D
    J Inorg Biochem; 2008; 102(5-6):1033-43. PubMed ID: 18226837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-target heteroleptic palladium bisphosphonate complexes.
    Cipriani M; Rostán S; León I; Li ZH; Gancheff JS; Kemmerling U; Olea Azar C; Etcheverry S; Docampo R; Gambino D; Otero L
    J Biol Inorg Chem; 2020 May; 25(3):509-519. PubMed ID: 32232584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.
    Yuan C; Lu L; Gao X; Wu Y; Guo M; Li Y; Fu X; Zhu M
    J Biol Inorg Chem; 2009 Aug; 14(6):841-51. PubMed ID: 19290551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis.
    Ravaschino EL; Docampo R; Rodriguez JB
    J Med Chem; 2006 Jan; 49(1):426-35. PubMed ID: 16392828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
    do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
    Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerobic oxidation reactions catalyzed by vanadium complexes of bis(phenolate) ligands.
    Zhang G; Scott BL; Wu R; Silks LA; Hanson SK
    Inorg Chem; 2012 Jul; 51(13):7354-61. PubMed ID: 22708725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New antiprotozoal agents: their synthesis and biological evaluations.
    Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
    Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
    Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
    Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
    Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
    J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of vanadium(V) hydrazido complexes with tris(2-hydroxyphenyl)amine ligands.
    Moriuchi T; Ikeuchi K; Hirao T
    Dalton Trans; 2013 Sep; 42(33):11824-30. PubMed ID: 23660688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.